All Articles

The Swiss crypto bank's partnership with Mesh is more than a tech update; it's a blueprint for how traditional finance can finally tame digital assets.

Foresight Enterprise VCT's new board appointments signal a dual focus on hands-on growth expertise and robust governance. What does this mean for its future?

A young Swiss wealth firm is making headlines with rapid growth and a new EU hub. We look beyond the press release to analyze the niche strategy fueling its rise.

BW LPG’s trading arm posted a $127 million realized gain, yet reported a net loss. A deep dive into the arcane world of mark-to-market accounting reveals a system under stress.

Beyond GLP-1, Boehringer Ingelheim’s new drug targets the brain's hunger signals, a calculated move in the high-stakes race for obesity treatment.

A landmark coalition between Japan's industrial giants and NVIDIA aims to pioneer 'physical AI,' creating a new generation of smart robots for factories and beyond.

Vietnam's FPT launches MediSight, an AI framework aiming to overhaul healthcare with intelligent agents and data reasoning, challenging established tech giants.

AST SpaceMobile secured $1 billion via complex convertible notes to accelerate its global network, a strategic bet that spooks investors with dilution fears.

A tragic suicide has exposed the dark side of AI companionship, sparking a veteran's mission to address a crisis of faith, mental health, and connection.

With profits rebounding and a major acquisition secured, GTPL Hathway's Q1 results signal a bold new phase of strategic expansion and technological ambition.

Korn Ferry's top RPO ranking isn't just a press release. It signals a market shift where AI, integrated consulting, and strategic foresight are the new table stakes.

With the hire of ANZ's former financial crime head, FTI Consulting is doubling down on a market facing intense regulatory pressure and evolving AI threats.

ASP Isotopes is cleaning house with a major debt-for-equity swap. It's more than accounting—it's a bold move to unleash a key player in the future of nuclear energy.

A landmark Chinatown asset returns to market with a S$10M price cut, testing investor appetite for heritage properties in a shifting economic landscape.

Great Southern Bancorp's Q2 earnings dip due to strategic cuts, but a closer look reveals a bank fortifying itself against industry headwinds.

A groundbreaking NEJM report shows Neutrolis's therapy rapidly reversed severe Lupus symptoms, validating a new, non-immunosuppressive approach.

A new partnership between Flexzo Ai and Maiden Lane Medical signals a major shift, using AI not just for efficiency but as a cure for the clinician shortage.

The cord blood pioneer reported a 56% profit surge despite a revenue dip. But a key dispute with Duke University has halted its ambitious expansion into therapy.

Infinity Natural Resources adds M&A architect Timothy Dugan to its board, a move analysts see as a clear signal of the shale driller's growth ambitions.